MAIA Biotechnology, Inc. (MAIA) stock
MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
$1.30+0.05 (+4.00%)
Close on Nov 18, 2026Market cap $79.07MP/E –Yield –
Earnings
MAIA Biotechnology's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q3 FY2023
–
EPS, Q3 FY2023
-$0.36
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of MAIA Biotechnology's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2023ended Sep 30, 2023 | Nov 7, 2023before the open | – | – | -$0.36 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 8, 2023before the open | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 8, 2023before the open | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 24, 2023after the close | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 9, 2022after the close | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 22, 2022before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
MAIA Biotechnology has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When MAIA Biotechnology puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases MAIA Biotechnology filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- News
- News
- News
- Update
- News
- News
- News
- News
- News
- News
- Update
- News
See a number that looks wrong?